Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Hicham Skali, M.D.

Title
Institution
Department
Address
Phone
Fax

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Skali H, Murthy VL, Paez D, Choi EM, Keng FYJ, Iain MA, Al-Mallah M, Campisi R, Bateman TM, Carrio I, Beanlands R, Calnon DA, Dilsizian V, Dondi M, Gimelli A, Pagnanelli R, Polk DM, Soman P, Einstein AJ, Dorbala S, Thompson RC. Guidance and best practices for reestablishment of non-emergent care in nuclear cardiology laboratories during the coronavirus disease 2019 (COVID-19) pandemic: An information statement from ASNC, IAEA, and SNMMI. J Nucl Med. 2020 Jul 24. PMID: 32709732.
    Citations:    
  2. Skali H, Murthy VL, Paez D, Choi EM, Keng FYJ, Iain MA, Al-Mallah M, Campisi R, Bateman TM, Carrio I, Beanlands R, Calnon DA, Dilsizian V, Dondi M, Gimelli A, Pagnanelli R, Polk DM, Soman P, Einstein AJ, Dorbala S, Thompson RC. Guidance and best practices for reestablishment of non-emergent care in nuclear cardiology laboratories during the coronavirus disease 2019 (COVID-19) pandemic: An information statement from ASNC, IAEA, and SNMMI : Endorsed by the Infectious Diseases Society of America. J Nucl Cardiol. 2020 Jul 24. PMID: 32710257.
    Citations:    
  3. Teramoto K, Nadruz Junior W, Matsushita K, Claggett B, John JE, Skali H, Solomon S, Cheng S, Shah AM. Mid- to Late-Life Time-Averaged Cumulative Blood Pressure and Late-Life Cardiac Structure, Function, and Heart Failure. Hypertension. 2020 Jun 15; HYPERTENSIONAHA12014833. PMID: 32536273.
    Citations:    
  4. Skali H, Murthy VL, Al-Mallah MH, Bateman TM, Beanlands R, Better N, Calnon DA, Dilsizian V, Gimelli A, Pagnanelli R, Polk DM, Soman P, Thompson RC, Einstein AJ, Dorbala S. Guidance and best practices for nuclear cardiology laboratories during the coronavirus disease 2019 (COVID-19) pandemic: An Information Statement from ASNC and SNMMI. J Nucl Cardiol. 2020 Jun; 27(3):1022-1029. PMID: 32415626.
    Citations:    
  5. Skali H, Murthy VL, Al-Mallah MH, Bateman TM, Beanlands R, Better N, Calnon DA, Dilsizian V, Gimelli A, Pagnanelli R, Polk DM, Soman P, Thompson RC, Einstein AJ, Dorbala S. Guidance and best practices for nuclear cardiology laboratories during the coronavirus disease 2019 (COVID-19) pandemic: An Information Statement from ASNC and SNMMI. J Nucl Med. 2020 May 15. PMID: 32414947.
    Citations:    
  6. Teramoto K, Sengelov M, West E, Santos M, Nadruz W, Skali H, Shah AM. Association of pulmonary hypertension and right ventricular function with exercise capacity in heart failure. ESC Heart Fail. 2020 Aug; 7(4):1635-1644. PMID: 32385945.
    Citations:    
  7. Shin SH, Claggett B, Pfeffer MA, Skali H, Liu J, Aguilar D, Diaz R, Dickstein K, Gerstein HC, Køber LV, Lawson FC, Lewis EF, Maggioni AP, McMurray JJV, Probstfield JL, Riddle MC, Tardif JC, Solomon SD. Hyperglycaemia, ejection fraction and the risk of heart failure or cardiovascular death in patients with type 2 diabetes and a recent acute coronary syndrome. Eur J Heart Fail. 2020 Mar 25. PMID: 32212368.
    Citations:    
  8. Bajaj NS, Singh A, Zhou W, Gupta A, Fujikura K, Byrne C, Harms HJ, Osborne MT, Bravo P, Andrikopolou E, Divakaran S, Bibbo CF, Hainer J, Skali H, Taqueti V, Steigner M, Dorbala S, Charytan DM, Prabhu SD, Blankstein R, Deo RC, Solomon SD, Di Carli MF. Coronary Microvascular Dysfunction, Left Ventricular Remodeling, and Clinical Outcomes in Patients With Chronic Kidney Impairment. Circulation. 2020 01 07; 141(1):21-33. PMID: 31779467.
    Citations:    
  9. Divakaran S, Singh A, DeFilippis EM, Churchill TW, Cuddy S, Ge Y, Ip IK, Zhou W, Skali H, Taqueti VR, Dorbala S, Spalding J, Xu Y, Khorasani R, Di Carli MF, Yialamas MA, Blankstein R. Appropriateness of inpatient stress testing: Implications for development of clinical decision support mechanisms and future criteria. J Nucl Cardiol. 2019 Nov 18. PMID: 31741326.
    Citations:    
  10. Myhre PL, Claggett B, Ballantyne CM, Selvin E, Røsjø H, Omland T, Solomon SD, Skali H, Shah AM. Association Between Circulating Troponin Concentrations, Left Ventricular Systolic and Diastolic Functions, and Incident Heart Failure in Older Adults. JAMA Cardiol. 2019 10 01; 4(10):997-1006. PMID: 31483438.
    Citations:    
  11. Partington SL, Valente AM, Bruyere J, Rosica D, Shafer KM, Landzberg MJ, Taqueti VR, Blankstein R, Skali H, Kwatra N, DiCarli MF, Grant FD, Dorbala S. Reducing radiation dose from myocardial perfusion imaging in subjects with complex congenital heart disease. J Nucl Cardiol. 2019 Aug 12. PMID: 31407235.
    Citations:    
  12. Divakaran S, Stewart GC, Lakdawala NK, Padera RF, Zhou W, Desai AS, Givertz MM, Mehra MR, Kwong RY, Hedgire SS, Ghoshhajra BB, Taqueti VR, Skali H, Dorbala S, Blankstein R, Di Carli MF. Diagnostic Accuracy of Advanced Imaging in Cardiac Sarcoidosis. Circ Cardiovasc Imaging. 2019 06; 12(6):e008975. PMID: 31177817.
    Citations:    
  13. Ramalho SHR, Santos M, Claggett B, Matsushita K, Kitzman DW, Loehr L, Solomon SD, Skali H, Shah AM. Association of Undifferentiated Dyspnea in Late Life With Cardiovascular and Noncardiovascular Dysfunction: A Cross-sectional Analysis From the ARIC Study. JAMA Netw Open. 2019 06 05; 2(6):e195321. PMID: 31199443.
    Citations:    
  14. Vita T, Murphy DJ, Osborne MT, Bajaj NS, Keraliya A, Jacob S, Diaz Martinez AJ, Nodoushani A, Bravo P, Hainer J, Bibbo CF, Steigner ML, Taqueti VR, Skali H, Blankstein R, Di Carli MF, Dorbala S. Association between Nonalcoholic Fatty Liver Disease at CT and Coronary Microvascular Dysfunction at Myocardial Perfusion PET/CT. Radiology. 2019 05; 291(2):330-337. PMID: 30835188.
    Citations:    
  15. Charytan DM, Himmelfarb J, Ikizler TA, Raj DS, Hsu JY, Landis JR, Anderson AH, Hung AM, Mehrotra R, Sharma S, Weiner DE, Williams M, DiCarli M, Skali H, Kimmel PL, Kliger AS, Dember LM. Safety and cardiovascular efficacy of spironolactone in dialysis-dependent ESRD (SPin-D): a randomized, placebo-controlled, multiple dosage trial. Kidney Int. 2019 04; 95(4):973-982. PMID: 30473139.
    Citations:    Fields:    
  16. Santos M, West E, Skali H, Forman DE, Nadruz W, Shah AM. Resting Heart Rate and Chronotropic Response to Exercise: Prognostic Implications in Heart Failure Across the Left Ventricular Ejection Fraction Spectrum. J Card Fail. 2018 Nov; 24(11):753-762. PMID: 30300684.
    Citations:    Fields:    
  17. Okada DR, Bravo PE, Vita T, Agarwal V, Osborne MT, Taqueti VR, Skali H, Chareonthaitawee P, Dorbala S, Stewart G, Di Carli M, Blankstein R. Erratum to: Isolated cardiac sarcoidosis: A focused review of an under-recognized entity. J Nucl Cardiol. 2018 Aug; 25(4):1147. PMID: 27681953.
    Citations: 1     Fields:    
  18. Nadruz W, West E, Sengeløv M, Grove GL, Santos M, Groarke JD, Forman DE, Claggett B, Skali H, Nohria A, Shah AM. Cardiovascular phenotype and prognosis of patients with heart failure induced by cancer therapy. Heart. 2019 01; 105(1):34-41. PMID: 29764969.
    Citations:    
  19. Nadruz W, Claggett B, Henglin M, Shah AM, Skali H, Rosamond WD, Folsom AR, Solomon SD, Cheng S. Widening Racial Differences in Risks for Coronary Heart Disease. Circulation. 2018 03 13; 137(11):1195-1197. PMID: 29530895.
    Citations:    Fields:    
  20. Vazir A, Claggett B, Cheng S, Skali H, Shah A, Agulair D, Ballantyne CM, Vardeny O, Solomon SD. Association of Resting Heart Rate and Temporal Changes in Heart Rate With Outcomes in Participants of the Atherosclerosis Risk in Communities Study. JAMA Cardiol. 2018 03 01; 3(3):200-206. PMID: 29365021.
    Citations: 1     Fields:    
  21. Vita T, Okada DR, Veillet-Chowdhury M, Bravo PE, Mullins E, Hulten E, Agrawal M, Madan R, Taqueti VR, Steigner M, Skali H, Kwong RY, Stewart GC, Dorbala S, Di Carli MF, Blankstein R. Complementary Value of Cardiac Magnetic Resonance Imaging and Positron Emission Tomography/Computed Tomography in the Assessment of Cardiac Sarcoidosis. Circ Cardiovasc Imaging. 2018 01; 11(1):e007030. PMID: 29335272.
    Citations: 2     Fields:    
  22. Nadruz W, West E, Sengeløv M, Santos M, Groarke JD, Forman DE, Claggett B, Skali H, Shah AM. Prognostic Value of Cardiopulmonary Exercise Testing in Heart Failure With Reduced, Midrange, and Preserved Ejection Fraction. J Am Heart Assoc. 2017 Oct 31; 6(11). PMID: 29089342.
    Citations:    Fields:    Translation:Humans
  23. Charytan DM, Skali H, Shah NR, Veeranna V, Cheezum MK, Taqueti VR, Kato T, Bibbo CR, Hainer J, Dorbala S, Blankstein R, Di Carli MF. Coronary flow reserve is predictive of the risk of cardiovascular death regardless of chronic kidney disease stage. Kidney Int. 2018 02; 93(2):501-509. PMID: 29032954.
    Citations:    Fields:    Translation:Humans
  24. Matsushita K, Kwak L, Sang Y, Ballew SH, Skali H, Shah AM, Coresh J, Solomon S. Kidney Disease Measures and Left Ventricular Structure and Function: The Atherosclerosis Risk in Communities Study. J Am Heart Assoc. 2017 Sep 22; 6(9). PMID: 28939714.
    Citations:    Fields:    Translation:Humans
  25. Nadruz W, Kitzman D, Windham BG, Kucharska-Newton A, Butler K, Palta P, Griswold ME, Wagenknecht LE, Heiss G, Solomon SD, Skali H, Shah AM. Cardiovascular Dysfunction and Frailty Among Older Adults in the Community: The ARIC Study. J Gerontol A Biol Sci Med Sci. 2017 Jul 01; 72(7):958-964. PMID: 27733425.
    Citations: 7     Fields:    Translation:Humans
  26. Nadruz W, Claggett B, Henglin M, Shah AM, Skali H, Rosamond WD, Folsom AR, Solomon SD, Cheng S. Racial Disparities in Risks of Stroke. N Engl J Med. 2017 05 25; 376(21):2089-2090. PMID: 28538119.
    Citations: 2     Fields:    Translation:Humans
  27. Skali H, Gerwien R, Meyer TE, Snider JV, Solomon SD, Stolen CM. Soluble ST2 and Risk of Arrhythmias, Heart Failure, or Death in Patients with Mildly Symptomatic Heart Failure: Results from MADIT-CRT. J Cardiovasc Transl Res. 2016 12; 9(5-6):421-428. PMID: 27798759.
    Citations: 2     Fields:    Translation:HumansCells
  28. Okada DR, Bravo PE, Vita T, Agarwal V, Osborne MT, Taqueti VR, Skali H, Chareonthaitawee P, Dorbala S, Stewart G, Di Carli M, Blankstein R. Isolated cardiac sarcoidosis: A focused review of an under-recognized entity. J Nucl Cardiol. 2018 08; 25(4):1136-1146. PMID: 27613395.
    Citations: 5     Fields:    
  29. Osborne MT, Hulten EA, Murthy VL, Skali H, Taqueti VR, Dorbala S, DiCarli MF, Blankstein R. Patient preparation for cardiac fluorine-18 fluorodeoxyglucose positron emission tomography imaging of inflammation. J Nucl Cardiol. 2017 02; 24(1):86-99. PMID: 27277502.
    Citations: 13     Fields:    Translation:Humans
  30. Lee MN, Skali H, Jarolim P. Persistently High Cardiac Troponin T with a Negative Cardiac Workup. Clin Chem. 2016 06; 62(6):896-7. PMID: 27235467.
    Citations:    Fields:    Translation:Humans
  31. Abdul-Rahim AH, Docherty KF, Skali H, Køber L, Dickstein K, Maggioni AP, Mareev V, Zannad F, Velazquez EJ, Califf RM, Pfeffer MA, Solomon SD, Lees KR, McMurray JJ. Effect of single and dual renin-angiotensin blockade on stroke in patients with and without diabetes in VALIANT. Eur Stroke J. 2016 Jun; 1(2):93-100. PMID: 31008270.
    Citations:    
  32. Nadruz W, West E, Santos M, Skali H, Groarke JD, Forman DE, Shah AM. Heart Failure and Midrange Ejection Fraction: Implications of Recovered Ejection Fraction for Exercise Tolerance and Outcomes. Circ Heart Fail. 2016 Apr; 9(4):e002826. PMID: 27009553.
    Citations: 6     Fields:    Translation:Humans
  33. Gori M, Gupta DK, Claggett B, Selvin E, Folsom AR, Matsushita K, Bello NA, Cheng S, Shah A, Skali H, Vardeny O, Ni H, Ballantyne CM, Astor BC, Klein BE, Aguilar D, Solomon SD. Natriuretic Peptide and High-Sensitivity Troponin for Cardiovascular Risk Prediction in Diabetes: The Atherosclerosis Risk in Communities (ARIC) Study. Diabetes Care. 2016 May; 39(5):677-85. PMID: 26740635.
    Citations: 4     Fields:    Translation:Humans
  34. Wang N, Hung CL, Shin SH, Claggett B, Skali H, Thune JJ, Køber L, Shah A, McMurray JJ, Pfeffer MA, Solomon SD. Regional cardiac dysfunction and outcome in patients with left ventricular dysfunction, heart failure, or both after myocardial infarction. Eur Heart J. 2016 Feb 01; 37(5):466-72. PMID: 26530103.
    Citations: 3     Fields:    Translation:Humans
  35. Skali H, Shah A, Cheng S, Claggett B, Liu J, Bello N, Aguilar D, Vardeny O, Matsushita K, Selvin E, Solomon S. Response to Letter Regarding Article, “Cardiac Structure and Function Across the Glycemic Spectrum in Elderly Men and Women Free of Prevalent Heart Disease: The Atherosclerosis Risk In the Community Study”. Circ Heart Fail. 2015 Sep; 8(5):1010. PMID: 26625500.
    Citations:    Fields:    Translation:Humans
  36. Beatty AL, Ku IA, Bibbins-Domingo K, Christenson RH, DeFilippi CR, Ganz P, Ix JH, Lloyd-Jones D, Omland T, Sabatine MS, Schiller NB, Shlipak MG, Skali H, Takeuchi M, Vittinghoff E, Whooley MA. Traditional Risk Factors Versus Biomarkers for Prediction of Secondary Events in Patients With Stable Coronary Heart Disease: From the Heart and Soul Study. J Am Heart Assoc. 2015 Jul 06; 4(7). PMID: 26150476.
    Citations: 6     Fields:    Translation:Humans
  37. Cheezum MK, Subramaniyam PS, Bittencourt MS, Hulten EA, Ghoshhajra BB, Shah NR, Forman DE, Hainer J, Leavitt M, Padmanabhan R, Skali H, Dorbala S, Hoffmann U, Abbara S, Di Carli MF, Gewirtz H, Blankstein R. Prognostic value of coronary CTA vs. exercise treadmill testing: results from the Partners registry. Eur Heart J Cardiovasc Imaging. 2015 Dec; 16(12):1338-46. PMID: 25899714.
    Citations: 4     Fields:    Translation:Humans
  38. Theilade S, Claggett B, Hansen TW, Skali H, Lewis EF, Solomon SD, Parving HH, Pfeffer M, McMurray JJ, Rossing P. Pulse pressure is not an independent predictor of outcome in type 2 diabetes patients with chronic kidney disease and anemia--the Trial to Reduce Cardiovascular Events with Aranesp Therapy (TREAT). J Hum Hypertens. 2016 Jan; 30(1):46-52. PMID: 25810068.
    Citations: 3     Fields:    Translation:Humans
  39. Dorbala S, Blankstein R, Skali H, Park MA, Fantony J, Mauceri C, Semer J, Moore SC, Di Carli MF. Approaches to reducing radiation dose from radionuclide myocardial perfusion imaging. J Nucl Med. 2015 Apr; 56(4):592-9. PMID: 25766891.
    Citations: 9     Fields:    Translation:Humans
  40. Skali H, Shah A, Gupta DK, Cheng S, Claggett B, Liu J, Bello N, Aguilar D, Vardeny O, Matsushita K, Selvin E, Solomon S. Cardiac structure and function across the glycemic spectrum in elderly men and women free of prevalent heart disease: the Atherosclerosis Risk In the Community study. Circ Heart Fail. 2015 May; 8(3):448-54. PMID: 25759458.
    Citations: 6     Fields:    Translation:Humans
  41. Lam CS, McEntegart M, Claggett B, Liu J, Skali H, Lewis E, Køber L, Rouleau J, Velazquez E, Califf R, McMurray JJ, Pfeffer M, Solomon S. Sex differences in clinical characteristics and outcomes after myocardial infarction: insights from the Valsartan in Acute Myocardial Infarction Trial (VALIANT). Eur J Heart Fail. 2015 Mar; 17(3):301-12. PMID: 25655011.
    Citations: 6     Fields:    Translation:Humans
  42. Vazir A, Claggett B, Jhund P, Castagno D, Skali H, Yusuf S, Swedberg K, Granger CB, McMurray JJ, Pfeffer MA, Solomon SD. Prognostic importance of temporal changes in resting heart rate in heart failure patients: an analysis of the CHARM program. Eur Heart J. 2015 Mar 14; 36(11):669-75. PMID: 25368202.
    Citations: 5     Fields:    Translation:Humans
  43. Kim Y, Matsushita K, Sang Y, Grams ME, Skali H, Shah AM, Hoogeveen RC, Solomon SD, Ballantyne CM, Coresh J. Association of high-sensitivity cardiac troponin T and natriuretic peptide with incident ESRD: the Atherosclerosis Risk in Communities (ARIC) study. Am J Kidney Dis. 2015 Apr; 65(4):550-8. PMID: 25446023.
    Citations: 1     Fields:    Translation:Humans
  44. Gupta DK, Skali H, Claggett B, Kasabov R, Cheng S, Shah AM, Loehr LR, Heiss G, Nambi V, Aguilar D, Wruck LM, Matsushita K, Folsom AR, Rosamond WD, Solomon SD. Heart failure risk across the spectrum of ankle-brachial index: the ARIC study (Atherosclerosis Risk In Communities). JACC Heart Fail. 2014 Oct; 2(5):447-54. PMID: 25194293.
    Citations: 5     Fields:    Translation:Humans
  45. Cheng S, Claggett B, Correia AW, Shah AM, Gupta DK, Skali H, Ni H, Rosamond WD, Heiss G, Folsom AR, Coresh J, Solomon SD. Temporal trends in the population attributable risk for cardiovascular disease: the Atherosclerosis Risk in Communities Study. Circulation. 2014 Sep 02; 130(10):820-8. PMID: 25210095.
    Citations: 21     Fields:    Translation:Humans
  46. Uno H, Claggett B, Tian L, Inoue E, Gallo P, Miyata T, Schrag D, Takeuchi M, Uyama Y, Zhao L, Skali H, Solomon S, Jacobus S, Hughes M, Packer M, Wei LJ. Moving beyond the hazard ratio in quantifying the between-group difference in survival analysis. J Clin Oncol. 2014 Aug 01; 32(22):2380-5. PMID: 24982461.
    Citations: 36     Fields:    Translation:Humans
  47. Bittencourt MS, Christman MP, Hulten E, Divakaran S, Skali H, Kwong RY, Hainer J, Forman DE, Kirshenbaum JM, Dorbala S, Di Carli MF, Blankstein R. Comparison of the use of downstream tests after exercise treadmill testing by cardiologists versus noncardiologists. Am J Cardiol. 2014 Jul 15; 114(2):305-11. PMID: 24874162.
    Citations: 2     Fields:    Translation:Humans
  48. Bello NA, Pfeffer MA, Skali H, McGill JB, Rossert J, Olson KA, Weinrauch L, Cooper ME, de Zeeuw D, Rossing P, McMurray JJ, Solomon SD. Retinopathy and clinical outcomes in patients with type 2 diabetes mellitus, chronic kidney disease, and anemia. BMJ Open Diabetes Res Care. 2014; 2(1):e000011. PMID: 25452859.
    Citations: 6     
  49. Skali H, Dwyer EM, Goldstein R, Haigney M, Krone R, Kukin M, Lichstein E, McNitt S, Moss AJ, Pfeffer MA, Solomon SD. Prognosis and response to therapy of first inpatient and outpatient heart failure event in a heart failure clinical trial: MADIT-CRT. Eur J Heart Fail. 2014 May; 16(5):560-5. PMID: 24578164.
    Citations: 5     Fields:    Translation:Humans
  50. Christman MP, Bittencourt MS, Hulten E, Saksena E, Hainer J, Skali H, Kwong RY, Forman DE, Dorbala S, O'Gara PT, Di Carli MF, Blankstein R. Yield of downstream tests after exercise treadmill testing: a prospective cohort study. J Am Coll Cardiol. 2014 Apr 08; 63(13):1264-1274. PMID: 24509269.
    Citations: 8     Fields:    Translation:Humans
  51. Gupta DK, Skali H, Rivero J, Campbell P, Griffin L, Smith C, Foster C, Claggett B, Glynn RJ, Couper G, Givertz MM, Mehra MR, Di Carli M, Solomon SD, Pfeffer MA. Assessment of myocardial viability and left ventricular function in patients supported by a left ventricular assist device. J Heart Lung Transplant. 2014 Apr; 33(4):372-81. PMID: 24582837.
    Citations: 3     Fields:    Translation:Humans
  52. Osborne MT, Hulten EA, Singh A, Waller AH, Bittencourt MS, Stewart GC, Hainer J, Murthy VL, Skali H, Dorbala S, Di Carli MF, Blankstein R. Reduction in ¹8F-fluorodeoxyglucose uptake on serial cardiac positron emission tomography is associated with improved left ventricular ejection fraction in patients with cardiac sarcoidosis. J Nucl Cardiol. 2014 Feb; 21(1):166-74. PMID: 24307261.
    Citations: 33     Fields:    Translation:Humans
  53. Shah AM, Cheng S, Skali H, Wu J, Mangion JR, Kitzman D, Matsushita K, Konety S, Butler KR, Fox ER, Cook N, Ni H, Coresh J, Mosley TH, Heiss G, Folsom AR, Solomon SD. Rationale and design of a multicenter echocardiographic study to assess the relationship between cardiac structure and function and heart failure risk in a biracial cohort of community-dwelling elderly persons: the Atherosclerosis Risk in Communities study. Circ Cardiovasc Imaging. 2014 Jan; 7(1):173-81. PMID: 24214885.
    Citations: 24     Fields:    Translation:Humans
  54. Blankstein R, Osborne M, Naya M, Waller A, Kim CK, Murthy VL, Kazemian P, Kwong RY, Tokuda M, Skali H, Padera R, Hainer J, Stevenson WG, Dorbala S, Di Carli MF. Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis. J Am Coll Cardiol. 2014 Feb 04; 63(4):329-36. PMID: 24140661.
    Citations: 76     Fields:    Translation:Humans
  55. Hsiao E, Ali B, Blankstein R, Skali H, Ali T, Bruyere J, Kwong RY, Di Carli MF, Dorbala S. Detection of obstructive coronary artery disease using regadenoson stress and 82Rb PET/CT myocardial perfusion imaging. J Nucl Med. 2013 Oct; 54(10):1748-54. PMID: 23940305.
    Citations: 12     Fields:    Translation:Humans
  56. Pfeffer MA, Skali H. PRAISE (prospective randomized amlodipine survival evaluation) and criticism. JACC Heart Fail. 2013 Aug; 1(4):315-317. PMID: 24621934.
    Citations: 1     Fields:    Translation:Humans
  57. Cheng S, Gupta DK, Claggett B, Sharrett AR, Shah AM, Skali H, Takeuchi M, Ni H, Solomon SD. Differential influence of distinct components of increased blood pressure on cardiovascular outcomes: from the atherosclerosis risk in communities study. Hypertension. 2013 Sep; 62(3):492-8. PMID: 23876475.
    Citations: 4     Fields:    Translation:Humans
  58. Skali H, Schulman AR, Dorbala S. (18)F-FDG PET/CT for the assessment of myocardial sarcoidosis. Curr Cardiol Rep. 2013 May; 15(5):352. PMID: 23504346.
    Citations: 14     Fields:    Translation:Humans
  59. Skali H, Schulman AR, Dorbala S. (18)F-FDG PET/CT for the Assessment of Myocardial Sarcoidosis. Curr Cardiol Rep. 2013 May; 15(5):370. PMID: 23553010.
    Citations:    
  60. Weinrauch LA, Desai AS, Skali H, D'Elia JA. Risk stratification of resistant hypertension in chronic kidney disease. J Am Coll Cardiol. 2013 Jun 18; 61(24):2468-2470. PMID: 23623913.
    Citations:    
  61. Skali H, Schulman AR, Dorbala S. 18F-FDG PET/CT for the assessment of myocardial sarcoidosis. Curr Cardiol Rep. 2013 Apr; 15(4):352. PMID: 23544184.
    Citations: 9     Fields:    Translation:Humans
  62. Skali H, Lin J, Pfeffer MA, Chen CY, Cooper ME, McMurray JJ, Nissenson AR, Remuzzi G, Rossert J, Parfrey PS, Scott-Douglas NW, Singh AK, Toto R, Uno H, Ivanovich P. Hemoglobin stability in patients with anemia, CKD, and type 2 diabetes: an analysis of the TREAT (Trial to Reduce Cardiovascular Events With Aranesp Therapy) placebo arm. Am J Kidney Dis. 2013 Feb; 61(2):238-46. PMID: 23159232.
    Citations: 3     Fields:    Translation:Humans
  63. Mousavi N, Shah PB, Skali H, Steigner M, Dorbala S, Di Carli MF, Blankstein R. Correlative imaging of spontaneous coronary artery dissection. J Nucl Cardiol. 2012 Jun; 19(3):625-9. PMID: 22456967.
    Citations:    Fields:    Translation:Humans
  64. Castagno D, Skali H, Takeuchi M, Swedberg K, Yusuf S, Granger CB, Michelson EL, Pfeffer MA, McMurray JJ, Solomon SD. Association of heart rate and outcomes in a broad spectrum of patients with chronic heart failure: results from the CHARM (Candesartan in Heart Failure: Assessment of Reduction in Mortality and morbidity) program. J Am Coll Cardiol. 2012 May 15; 59(20):1785-95. PMID: 22575317.
    Citations: 22     Fields:    Translation:Humans
  65. Partington SL, Lanka V, Hainer J, Blankstein R, Skali H, Forman DE, Di Carli MF, Dorbala S. Safety and feasibility of regadenoson use for suboptimal heart rate response during symptom-limited standard Bruce exercise stress test. J Nucl Cardiol. 2012 Oct; 19(5):970-8. PMID: 22565239.
    Citations: 24     Fields:    Translation:Humans
  66. Barkoudah E, Skali H, Uno H, Solomon SD, Pfeffer MA. Mortality rates in trials of subjects with type 2 diabetes. J Am Heart Assoc. 2012 Feb; 1(1):8-15. PMID: 23130114.
    Citations: 12     Fields:    
  67. Skali H, Parving HH, Parfrey PS, Burdmann EA, Lewis EF, Ivanovich P, Keithi-Reddy SR, McGill JB, McMurray JJ, Singh AK, Solomon SD, Uno H, Pfeffer MA. Stroke in patients with type 2 diabetes mellitus, chronic kidney disease, and anemia treated with Darbepoetin Alfa: the trial to reduce cardiovascular events with Aranesp therapy (TREAT) experience. Circulation. 2011 Dec 20; 124(25):2903-8. PMID: 22104547.
    Citations: 21     Fields:    Translation:Humans
  68. Skali H, Solomon SD. Reducing infarct size with EPO in patients with ST-segment elevation myocardial infarction. Am J Kidney Dis. 2011 Dec; 58(6):876-8. PMID: 21962617.
    Citations:    Fields:    
  69. Shah AM, Shin SH, Takeuchi M, Skali H, Desai AS, Køber L, Maggioni AP, Rouleau JL, Kelly RY, Hester A, Keefe D, McMurray JJ, Pfeffer MA, Solomon SD. Left ventricular systolic and diastolic function, remodelling, and clinical outcomes among patients with diabetes following myocardial infarction and the influence of direct renin inhibition with aliskiren. Eur J Heart Fail. 2012 Feb; 14(2):185-92. PMID: 21965526.
    Citations: 8     Fields:    Translation:Humans
  70. Shah AM, Hung CL, Shin SH, Skali H, Verma A, Ghali JK, Køber L, Velazquez EJ, Rouleau JL, McMurray JJ, Pfeffer MA, Solomon SD. Cardiac structure and function, remodeling, and clinical outcomes among patients with diabetes after myocardial infarction complicated by left ventricular systolic dysfunction, heart failure, or both. Am Heart J. 2011 Oct; 162(4):685-91. PMID: 21982661.
    Citations: 5     Fields:    Translation:Humans
  71. Mennicke M, Gulati K, Oliva I, Goldflam K, Skali H, Ledbetter S, Platz E. Anatomical distribution of traumatic pneumothoraces on chest computed tomography: implications for ultrasound screening in the ED. Am J Emerg Med. 2012 Sep; 30(7):1025-31. PMID: 21908143.
    Citations: 1     Fields:    Translation:Humans
  72. Skali H, Uno H, Levey AS, Inker LA, Pfeffer MA, Solomon SD. Prognostic assessment of estimated glomerular filtration rate by the new Chronic Kidney Disease Epidemiology Collaboration equation in comparison with the Modification of Diet in Renal Disease Study equation. Am Heart J. 2011 Sep; 162(3):548-54. PMID: 21884875.
    Citations: 39     Fields:    Translation:Humans
  73. Chandra S, Skali H, Blankstein R. Novel techniques for assessment of left ventricular systolic function. Heart Fail Rev. 2011 Jul; 16(4):327-37. PMID: 21153879.
    Citations: 3     Fields:    Translation:Humans
  74. Verma A, Pfeffer MA, Skali H, Rouleau J, Maggioni A, McMurray JJ, Califf RM, Velazquez EJ, Solomon SD. Incremental value of echocardiographic assessment beyond clinical evaluation for prediction of death and development of heart failure after high-risk myocardial infarction. Am Heart J. 2011 Jun; 161(6):1156-62. PMID: 21641363.
    Citations:    Fields:    Translation:Humans
  75. Solomon SD, Shin SH, Shah A, Skali H, Desai A, Kober L, Maggioni AP, Rouleau JL, Kelly RY, Hester A, McMurray JJ, Pfeffer MA. Effect of the direct renin inhibitor aliskiren on left ventricular remodelling following myocardial infarction with systolic dysfunction. Eur Heart J. 2011 May; 32(10):1227-34. PMID: 21317148.
    Citations: 32     Fields:    Translation:Humans
  76. Pouleur AC, Barkoudah E, Uno H, Skali H, Finn PV, Zelenkofske SL, Belenkov YN, Mareev V, Velazquez EJ, Rouleau JL, Maggioni AP, Køber L, Califf RM, McMurray JJ, Pfeffer MA, Solomon SD. Pathogenesis of sudden unexpected death in a clinical trial of patients with myocardial infarction and left ventricular dysfunction, heart failure, or both. Circulation. 2010 Aug 10; 122(6):597-602. PMID: 20660803.
    Citations: 43     Fields:    Translation:HumansCTClinical Trials
  77. Wu JC, Ho CY, Skali H, Abichandani R, Wilcox WR, Banikazemi M, Packman S, Sims K, Solomon SD. Cardiovascular manifestations of Fabry disease: relationships between left ventricular hypertrophy, disease severity, and alpha-galactosidase A activity. Eur Heart J. 2010 May; 31(9):1088-97. PMID: 20061327.
    Citations: 8     Fields:    Translation:HumansCTClinical Trials
  78. Verma A, Meris A, Skali H, Ghali JK, Arnold JM, Bourgoun M, Velazquez EJ, McMurray JJ, Kober L, Pfeffer MA, Califf RM, Solomon SD. Prognostic implications of left ventricular mass and geometry following myocardial infarction: the VALIANT (VALsartan In Acute myocardial iNfarcTion) Echocardiographic Study. JACC Cardiovasc Imaging. 2008 Sep; 1(5):582-91. PMID: 19356485.
    Citations: 49     Fields:    Translation:Humans
  79. Knecht S, Skali H, O'Neill MD, Wright M, Matsuo S, Chaudhry GM, Haffajee CI, Nault I, Gijsbers GH, Sacher F, Laurent F, Montaudon M, Corneloup O, Hocini M, Haïssaguerre M, Orlov MV, Jaïs P. Computed tomography-fluoroscopy overlay evaluation during catheter ablation of left atrial arrhythmia. Europace. 2008 Aug; 10(8):931-8. PMID: 18511437.
    Citations: 15     Fields:    Translation:HumansCTClinical Trials
  80. Smeglin A, Ansari M, Skali H, Oo TH, Maysky M. Marantic endocarditis and disseminated intravascular coagulation with systemic emboli in presentation of pancreatic cancer. J Clin Oncol. 2008 Mar 10; 26(8):1383-5. PMID: 18323562.
    Citations: 4     Fields:    Translation:Humans
  81. Anavekar NS, Skali H, Bourgoun M, Ghali JK, Kober L, Maggioni AP, McMurray JJ, Velazquez E, Califf R, Pfeffer MA, Solomon SD. Usefulness of right ventricular fractional area change to predict death, heart failure, and stroke following myocardial infarction (from the VALIANT ECHO Study). Am J Cardiol. 2008 Mar 01; 101(5):607-12. PMID: 18308007.
    Citations: 45     Fields:    Translation:Humans
  82. Anderson RE, Pfeffer MA, Thune JJ, McMurray JJ, Califf RM, Velazquez E, White HD, Rouleau JL, Skali H, Maggioni A, Solomon SD. High-risk myocardial infarction in the young: the VALsartan In Acute myocardial iNfarcTion (VALIANT) trial. Am Heart J. 2008 Apr; 155(4):706-11. PMID: 18371480.
    Citations: 5     Fields:    Translation:Humans
  83. Solomon SD, Dobson J, Pocock S, Skali H, McMurray JJ, Granger CB, Yusuf S, Swedberg K, Young JB, Michelson EL, Pfeffer MA. Influence of nonfatal hospitalization for heart failure on subsequent mortality in patients with chronic heart failure. Circulation. 2007 Sep 25; 116(13):1482-7. PMID: 17724259.
    Citations: 79     Fields:    Translation:Humans
  84. Kenchaiah S, Pocock SJ, Wang D, Finn PV, Zornoff LA, Skali H, Pfeffer MA, Yusuf S, Swedberg K, Michelson EL, Granger CB, McMurray JJ, Solomon SD. Body mass index and prognosis in patients with chronic heart failure: insights from the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program. Circulation. 2007 Aug 07; 116(6):627-36. PMID: 17638930.
    Citations: 54     Fields:    Translation:Humans
  85. Anavekar NS, Gerson D, Skali H, Kwong RY, Yucel EK, Solomon SD. Two-dimensional assessment of right ventricular function: an echocardiographic-MRI correlative study. Echocardiography. 2007 May; 24(5):452-6. PMID: 17456062.
    Citations: 54     Fields:    Translation:Humans
  86. Amigoni M, Meris A, Thune JJ, Mangalat D, Skali H, Bourgoun M, Warnica JW, Barvik S, Arnold JM, Velazquez EJ, Van de Werf F, Ghali J, McMurray JJ, Køber L, Pfeffer MA, Solomon SD. Mitral regurgitation in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both: prognostic significance and relation to ventricular size and function. Eur Heart J. 2007 Feb; 28(3):326-33. PMID: 17251259.
    Citations: 13     Fields:    Translation:Humans
  87. Thune JJ, Køber L, Pfeffer MA, Skali H, Anavekar NS, Bourgoun M, Ghali JK, Arnold JM, Velazquez EJ, Solomon SD. Comparison of regional versus global assessment of left ventricular function in patients with left ventricular dysfunction, heart failure, or both after myocardial infarction: the valsartan in acute myocardial infarction echocardiographic study. J Am Soc Echocardiogr. 2006 Dec; 19(12):1462-5. PMID: 17138030.
    Citations: 13     Fields:    Translation:Humans
  88. Stephenson K, Skali H, McMurray JJ, Velazquez EJ, Aylward PG, Kober L, Van de Werf F, White HD, Pieper KS, Califf RM, Solomon SD, Pfeffer MA. Long-term outcomes of left bundle branch block in high-risk survivors of acute myocardial infarction: the VALIANT experience. Heart Rhythm. 2007 Mar; 4(3):308-13. PMID: 17341394.
    Citations: 1     Fields:    Translation:Humans
  89. Skali H, Pfeffer MA, Lubsen J, Solomon SD. Variable impact of combining fatal and nonfatal end points in heart failure trials. Circulation. 2006 Nov 21; 114(21):2298-303. PMID: 17116781.
    Citations: 4     Fields:    Translation:Humans
  90. Jose P, Skali H, Anavekar N, Tomson C, Krumholz HM, Rouleau JL, Moye L, Pfeffer MA, Solomon SD. Increase in creatinine and cardiovascular risk in patients with systolic dysfunction after myocardial infarction. J Am Soc Nephrol. 2006 Oct; 17(10):2886-91. PMID: 16928807.
    Citations: 38     Fields:    Translation:Humans
  91. Jose P, Tomson C, Skali H, Rouleau J, Braunwald E, Arnold JM, Cuddy T, Sussex B, Bernstein V, Pfeffer M, Solomon S. Influence of proteinuria on cardiovascular risk and response to angiotensin-converting enzyme inhibition after myocardial infarction. J Am Coll Cardiol. 2006 Apr 18; 47(8):1725-7. PMID: 16631015.
    Citations: 3     Fields:    Translation:Humans
  92. Yerra L, Anavekar N, Skali H, Zelenkofske S, Velazquez E, McMurray J, Pfeffer M, Solomon SD. Association of QRS duration and outcomes after myocardial infarction: the VALIANT trial. Heart Rhythm. 2006 Mar; 3(3):313-6. PMID: 16500304.
    Citations: 5     Fields:    Translation:Humans
  93. Anavekar NS, Mirza A, Skali H, Plappert T, St John Sutton M, Pfeffer MA, Solomon SD. Risk assessment in patients with depressed left ventricular function after myocardial infarction using the myocardial performance index--Survival and Ventricular Enlargement (SAVE) experience. J Am Soc Echocardiogr. 2006 Jan; 19(1):28-33. PMID: 16423666.
    Citations: 1     Fields:    Translation:Humans
  94. Solomon SD, Anavekar N, Skali H, McMurray JJ, Swedberg K, Yusuf S, Granger CB, Michelson EL, Wang D, Pocock S, Pfeffer MA. Influence of ejection fraction on cardiovascular outcomes in a broad spectrum of heart failure patients. Circulation. 2005 Dec 13; 112(24):3738-44. PMID: 16330684.
    Citations: 94     Fields:    Translation:Humans
  95. Skali H, Zornoff LA, Pfeffer MA, Arnold MO, Lamas GA, Moyé LA, Plappert T, Rouleau JL, Sussex BA, St John Sutton M, Braunwald E, Solomon SD. Prognostic use of echocardiography 1 year after a myocardial infarction. Am Heart J. 2005 Oct; 150(4):743-9. PMID: 16209977.
    Citations:    Fields:    Translation:Humans
  96. Solomon SD, Skali H, Bourgoun M, Fang J, Ghali JK, Martelet M, Wojciechowski D, Ansmite B, Skards J, Laks T, Henry D, Packer M, Pfeffer MA. Effect of angiotensin-converting enzyme or vasopeptidase inhibition on ventricular size and function in patients with heart failure: the Omapatrilat Versus Enalapril Randomized Trial of Utility in Reducing Events (OVERTURE) echocardiographic study. Am Heart J. 2005 Aug; 150(2):257-62. PMID: 16086927.
    Citations: 9     Fields:    Translation:Humans
  97. Scridon T, Scridon C, Skali H, Alvarez A, Goldhaber SZ, Solomon SD. Prognostic significance of troponin elevation and right ventricular enlargement in acute pulmonary embolism. Am J Cardiol. 2005 Jul 15; 96(2):303-5. PMID: 16018861.
    Citations: 5     Fields:    Translation:Humans
  98. Solomon SD, Skali H, Anavekar NS, Bourgoun M, Barvik S, Ghali JK, Warnica JW, Khrakovskaya M, Arnold JM, Schwartz Y, Velazquez EJ, Califf RM, McMurray JV, Pfeffer MA. Changes in ventricular size and function in patients treated with valsartan, captopril, or both after myocardial infarction. Circulation. 2005 Jun 28; 111(25):3411-9. PMID: 15967846.
    Citations: 48     Fields:    Translation:Humans
  99. Tokmakova MP, Skali H, Kenchaiah S, Braunwald E, Rouleau JL, Packer M, Chertow GM, Moyé LA, Pfeffer MA, Solomon SD. Chronic kidney disease, cardiovascular risk, and response to angiotensin-converting enzyme inhibition after myocardial infarction: the Survival And Ventricular Enlargement (SAVE) study. Circulation. 2004 Dec 14; 110(24):3667-73. PMID: 15569840.
    Citations: 24     Fields:    Translation:HumansCTClinical Trials
  100. Murcia AM, Hennekens CH, Lamas GA, Jiménez-Navarro M, Rouleau JL, Flaker GC, Goldman S, Skali H, Braunwald E, Pfeffer MA. Impact of diabetes on mortality in patients with myocardial infarction and left ventricular dysfunction. Arch Intern Med. 2004 Nov 08; 164(20):2273-9. PMID: 15534166.
    Citations: 35     Fields:    Translation:HumansCTClinical Trials
  101. Solomon SD, Wang D, Finn P, Skali H, Zornoff L, McMurray JJ, Swedberg K, Yusuf S, Granger CB, Michelson EL, Pocock S, Pfeffer MA. Effect of candesartan on cause-specific mortality in heart failure patients: the Candesartan in Heart failure Assessment of Reduction in Mortality and morbidity (CHARM) program. Circulation. 2004 Oct 12; 110(15):2180-3. PMID: 15466644.
    Citations: 36     Fields:    Translation:HumansCTClinical Trials
  102. Aguilar D, Solomon SD, Køber L, Rouleau JL, Skali H, McMurray JJ, Francis GS, Henis M, O'Connor CM, Diaz R, Belenkov YN, Varshavsky S, Leimberger JD, Velazquez EJ, Califf RM, Pfeffer MA. Newly diagnosed and previously known diabetes mellitus and 1-year outcomes of acute myocardial infarction: the VALsartan In Acute myocardial iNfarcTion (VALIANT) trial. Circulation. 2004 Sep 21; 110(12):1572-8. PMID: 15364810.
    Citations: 37     Fields:    Translation:Humans
  103. Aguilar D, Skali H, Moyé LA, Lewis EF, Gaziano JM, Rutherford JD, Hartley LH, Randall OS, Geltman EM, Lamas GA, Rouleau JL, Pfeffer MA, Solomon SD. Alcohol consumption and prognosis in patients with left ventricular systolic dysfunction after a myocardial infarction. J Am Coll Cardiol. 2004 Jun 02; 43(11):2015-21. PMID: 15172406.
    Citations: 9     Fields:    Translation:HumansCTClinical Trials
  104. Solomon SD, St John Sutton M, Lamas GA, Plappert T, Rouleau JL, Skali H, Moyé L, Braunwald E, Pfeffer MA. Ventricular remodeling does not accompany the development of heart failure in diabetic patients after myocardial infarction. Circulation. 2002 Sep 03; 106(10):1251-5. PMID: 12208801.
    Citations: 15     Fields:    Translation:HumansCTClinical Trials
  105. Zornoff LA, Skali H, Pfeffer MA, St John Sutton M, Rouleau JL, Lamas GA, Plappert T, Rouleau JR, Moyé LA, Lewis SJ, Braunwald E, Solomon SD. Right ventricular dysfunction and risk of heart failure and mortality after myocardial infarction. J Am Coll Cardiol. 2002 May 01; 39(9):1450-5. PMID: 11985906.
    Citations: 74     Fields:    Translation:HumansCTClinical Trials
  106. Skali H, Solomon SD, Pfeffer MA. Are we asking too much of our trials? Am Heart J. 2002 Jan; 143(1):1-3. PMID: 11773904.
    Citations: 2     Fields:    Translation:Humans
  107. Skali H, Pfeffer MA. Prospects for ARB in the next five years. J Renin Angiotensin Aldosterone Syst. 2001 Dec; 2(4):215-8. PMID: 11881126.
    Citations:    Fields:    Translation:Humans
  108. Hicham Skali Lami. Child Sexual Abuse. Medico-legal Aspects. Experience of the Casablanca Appeal Court. 1998.
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Skali's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (297)
Explore
_
Co-Authors (64)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.